VNRX vs PACB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

VNRX

39.2
AI Score
VS
PACB Wins

PACB

49.8
AI Score

Investment Advisor Scores

VNRX

39score
Recommendation
SELL

PACB

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric VNRX PACB Winner
Revenue 1.38M 76.19M PACB
Net Income -13.99M -53.02M VNRX
Net Margin -1011.1% -69.6% PACB
Operating Income -9.53M -52.97M VNRX
ROE 43.5% 159.6% PACB
ROA -168.5% -7.1% PACB
Total Assets 8.30M 751.85M PACB
Cash 2.80M 61.00M PACB
Current Ratio 0.30 4.92 PACB
Free Cash Flow -10.45M -84.87M VNRX

Relative Price Performance (Last 90 Days)

VNRX 1M: -34.2% · 3M: -83.7% PACB 1M: +55.7% · 3M: +61.4%

Current Technical Phase

VNRX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -46.6%), weak momentum, RSI 21

RSI (14): 21.2 · Price: $0.16

PACB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (24.9% over 20 days), RSI 57

RSI (14): 57.3 · Price: $2.20

Fundamentals Snapshot

Metric VNRX PACB
Market Cap — —
Forward P/E -0.2 -5.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 1.0% 0.3%
Operating Margin -10.4% -1.1%
EPS -3.80 -0.43
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PACB is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.